A High-Throughput Immune-Oncology Screen Identifies Immunostimulatory Properties of Cytotoxic Chemotherapy Agents in TNBC is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI
Grant: F31CA271790-01A1 (KKB)
NCI
Grant: CA243326 (AR)
NCI
Grant: R50-CA211206 (JAB)
NCI
Grant: S10 ODO28719
NCI
Grant: S10 ODO28715
NCI
Grant: P30 CA68485
NCI NIH HHS
Grant: R50 CA211206
NIH HHS
Grant: 1S10CA028719-05A1
NIH HHS
Grant: S10 OD028719
NCI NIH HHS
Grant: P30 CA068485
NCI NIH HHS
Grant: R01 CA243326
NIH HHS
Grant: S10 OD028715
NCI NIH HHS
Grant: F31 CA271790
National Institutes of Health
Grant: 3P30CA068485-23S2
Cancer Center Support Grant
National Institutes of Health
Grant: 5R01CA243326-05
Optimizing Response to Immune Checkpoint Inhibitor Therapy for Breast Cancer: A Role for Inhibitors of the PI3K pathway
National Institutes of Health
Grant: 5R50CA211206-08
Cancer Pharmacologist and HTS Scientist
National Institutes of Health
Grant: 5F31CA271790-02
Enhancing triple negative breast cancer response to immune checkpoint inhibitor therapy via targeted therapies
FWCI
0.18
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals